MariMed Statistics
Total Valuation
MariMed has a market cap or net worth of 39.83 million. The enterprise value is 138.27 million.
| Market Cap | 39.83M |
| Enterprise Value | 138.27M |
Important Dates
The last earnings date was Monday, March 3, 2025.
| Earnings Date | Mar 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MariMed has 382.17 million shares outstanding. The number of shares has increased by 4.33% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 382.17M |
| Shares Change (YoY) | +4.33% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 10.17% |
| Owned by Institutions (%) | 0.29% |
| Float | 343.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.25 |
| PB Ratio | 0.65 |
| P/TBV Ratio | 1.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.23, with an EV/FCF ratio of -26.72.
| EV / Earnings | -11.37 |
| EV / Sales | 0.88 |
| EV / EBITDA | 8.23 |
| EV / EBIT | 35.79 |
| EV / FCF | -26.72 |
Financial Position
The company has a current ratio of 1.10, with a Debt / Equity ratio of 1.12.
| Current Ratio | 1.10 |
| Quick Ratio | 0.34 |
| Debt / Equity | 1.12 |
| Debt / EBITDA | 5.27 |
| Debt / FCF | -17.10 |
| Interest Coverage | 0.56 |
Financial Efficiency
Return on equity (ROE) is -14.45% and return on invested capital (ROIC) is 1.44%.
| Return on Equity (ROE) | -14.45% |
| Return on Assets (ROA) | 1.20% |
| Return on Invested Capital (ROIC) | 1.44% |
| Return on Capital Employed (ROCE) | 2.44% |
| Revenue Per Employee | 204,088 |
| Profits Per Employee | -15,716 |
| Employee Count | 721 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 3.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.69% in the last 52 weeks. The beta is 2.69, so MariMed's price volatility has been higher than the market average.
| Beta (5Y) | 2.69 |
| 52-Week Price Change | -59.69% |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 0.16 |
| Relative Strength Index (RSI) | 41.25 |
| Average Volume (20 Days) | 332,716 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.39 |
Income Statement
In the last 12 months, MariMed had revenue of 157.96 million and -12.16 million in losses. Loss per share was -0.03.
| Revenue | 157.96M |
| Gross Profit | 62.87M |
| Operating Income | 3.86M |
| Pretax Income | -3.97M |
| Net Income | -12.16M |
| EBITDA | 14.72M |
| EBIT | 3.86M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 7.28 million in cash and 88.47 million in debt, giving a net cash position of -81.19 million or -0.21 per share.
| Cash & Cash Equivalents | 7.28M |
| Total Debt | 88.47M |
| Net Cash | -81.19M |
| Net Cash Per Share | -0.21 |
| Equity (Book Value) | 78.88M |
| Book Value Per Share | 0.16 |
| Working Capital | 4.83M |
Cash Flow
In the last 12 months, operating cash flow was 6.79 million and capital expenditures -11.96 million, giving a free cash flow of -5.18 million.
| Operating Cash Flow | 6.79M |
| Capital Expenditures | -11.96M |
| Free Cash Flow | -5.18M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 39.80%, with operating and profit margins of 2.45% and -7.70%.
| Gross Margin | 39.80% |
| Operating Margin | 2.45% |
| Pretax Margin | -2.51% |
| Profit Margin | -7.70% |
| EBITDA Margin | 9.32% |
| EBIT Margin | 2.45% |
| FCF Margin | n/a |
Dividends & Yields
MariMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.33% |
| Shareholder Yield | -4.33% |
| Earnings Yield | -30.54% |
| FCF Yield | -12.99% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MariMed has an Altman Z-Score of 0.47. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.47 |
| Piotroski F-Score | n/a |